Create a free research account to view current pricing and place an order.
Mechanism of action
FOXO4-DRI is researched as a senolytic peptide concept intended to disrupt FOXO4-p53 interactions in senescent-cell models. Human use parameters and formulation standards are not established.
Half-life & pharmacokinetics
Half-life: Not standardized.
Human PK is not standardized. This is a high-caution investigational senolytic concept rather than a routine peptide protocol.
Research dosing reference
0.5-2 mg intermittent research exposure; formal clinical dosing is not standardized.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | DMSO or compatible solvent system may be required; verify formulation | Variable |
Injection timing
Intermittent use only in tightly structured research contexts.
Beginner escalation
Do not escalate casually; senolytic concepts require review-driven protocols.
Side-effect mitigation
Monitor systemic tolerance, inflammatory response, fatigue, and unexpected adverse effects.
Stack compatibility
Avoid stacking with other aggressive senolytic, immune-active, or mitochondrial stressors initially.
Storage & stability
Solvent choice is formulation-specific. Protect from heat/light; avoid assuming BAC compatibility.
Protocol duration & reassessment
High-caution investigational exposure only. Use short, tightly defined courses with extended reassessment intervals; do not repeat until tolerance, objective markers, and risk/benefit are reviewed. Bioregulators / Organ Support
Frequently asked questions
What is FOXO4 and how does it work?
FOXO4-DRI is researched as a senolytic peptide concept intended to disrupt FOXO4-p53 interactions in senescent-cell models. Human use parameters and formulation standards are not established.
What is the half-life of FOXO4?
FOXO4: Not standardized. Human PK is not standardized. This is a high-caution investigational senolytic concept rather than a routine peptide protocol.
How is FOXO4 reconstituted for research?
Preferred reconstitution for the 10 mg vial is DMSO or compatible solvent system may be required; verify formulation, giving Variable. Always confirm concentration math before any use. Research use only.
Is FOXO4 FDA approved?
No. FOXO4 is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration